We expect Monsanto's near-term performance to improve on the back of Bayer AG's BAYRY buyout deal. The largest all-cash deal ($66 billion), which awaits regulatory approvals, is anticipated to close by the end of 2017. The transaction is likely to open up a number of opportunities for the company. This, in turn, would propel Monsanto's growth.